Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Valera adopted as new name for Hydro Med Sciences

Sep. 9, 2003

Biphenyl-based antiandrogenic agents covered by Endorecherche patent

Sep. 9, 2003

Novel GnRH modulators prepared and tested by Pfizer researchers

Sep. 9, 2003

GW-572016, a dual EGFR/ErbB-2 TK inhibitor, discussed in ACS presentation

Sep. 8, 2003

Bicyclic androgen receptor antagonists pursued at BMS

Sep. 8, 2003

Japanese group identifies new antiangiogenic/antimetastatic MMP inhibitor

Sep. 8, 2003

Micromet to develop CAT's EpCAM-targeting antibody

Sep. 8, 2003

Two new phase I trials investigate Xcytrin plus Taxotere for advanced cancers

Sep. 8, 2003

Kylix describes new Tie-2/KDR inhibitors and their use

Sep. 5, 2003

Avidex and Dow to develop biotargeted radiopharmaceuticals for cancer

Sep. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...